The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Molecular genetics of early-onset Alzheimer’s disease revisited
Open accessAbstract
As the discovery of the Alzheimer's disease (AD) genes, APP, PSEN1, and PSEN2, in families with autosomal dominant early-onset AD (EOAD), gene discovery in familial EOAD came more or less to a standstill. Only 5% of EOAD patients are carrying a pathogenic mutation in one of the AD genes or a apolipoprotein E (APOE) risk allele ε4, most of EOAD patients remain unexplained. Here, we aimed at summarizing the current knowledge of EOAD genetics and its role in ongoing approaches to understand the biology of AD and disease symptomatology as well as developing new therapeutics. Next, we explored the possible molecular mechanisms that might underlie the missing genetic etiology of EOAD and discussed how the use of massive parallel sequencing technologies triggered novel gene discoveries. To conclude, we commented on the relevance of reinvestigating EOAD patients as a means to explore potential new avenues for translational research and therapeutic discoveries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These rare mutations cause the aggregation of amyloid proteins, leading to the progression of early onset AD.”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [157]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“But it was until 1980s that three genes, including APP, PSEN1, and PSEN2, were found to be responsible for early onset AD.157”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [157]
Experimental — accuracy not yet measuredIn the citing paper
“PSEN2 mutations are much rarer, with only around 30 mutations identified in ADAD families [2].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“A majority of ADAD families carry a pathogenic mutation in one of three genes: APP, presenilin 1 (PSEN1), or presenilin 2 (PSEN2) [2, 33].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“To date, more than 50 highly penetrant mutations have been identified in APP [2].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“ADAD is very rare, accounting for less than <1% of all cases of AD [2, 31–33]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“While mutations in these genes are the most well-studied mutations associated with EOAD, it is estimated that a significant portion of EOAD remains unexplained genetically [2].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“Gene duplications of APP are well-known to cause AD, with as many as 25 duplications of variable length associated with AD in EOAD families [2]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“The large variability in the age at onset of AD symptoms even among families who share common pathogenic mutations [31]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Self-citationStrittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 617
Somatic mutations in neurons during aging and neurodegeneration
Verheijen, B. M., Vermulst, M., & van Leeuwen, F. W. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1850-y · Cited by 60
Greotti, E., Capitanio, P., Wong, A., Pozzan, T., Pizzo, P., & Pendin, D. (2019) · Cell Calcium · doi:10.1016/j.ceca.2019.02.005 · Cited by 55
Autophagy-lysosome dysfunction is involved in Aβ deposition in STZ-induced diabetic rats
Ma, L., Lv, Y.-L., Huo, K., Liu, J., Shang, S., Fei, Y., Li, Y., Zhao, B., Wei, M., Deng, Y., et al. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.10.031 · Cited by 55
Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model
Sawa, M., Overk, C., Becker, A., Derse, D., Albay, R., Weldy, K., Salehi, A., Beach, T. G., Doran, E., Head, E., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12463 · Cited by 54
Genetic Phenotypes of Alzheimer’s Disease: Mechanisms and Potential Therapy
Quan, M., Cao, S., Wang, Q., Wang, S., & Jia, J. (2023) · Phenomics · doi:10.1007/s43657-023-00098-x · Cited by 62
Alzheimer’s Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology
Agarwal, M., Alam, R., Haider, M. K., Malik, M. Z., & Kim, D.-K. (2020) · Nanomaterials · doi:10.3390/nano11010059 · Cited by 59
Symptomatic, Genetic, and Mechanistic Overlaps between Autism and Alzheimer’s Disease
Nadeem, M. S., Hosawi, S. B. I., Alshehri, S., Ghoneim, M. M., Imam, S. S., Murtaza, B. N., & Kazmi, I. A. (2021) · Biomolecules · doi:10.3390/biom11111635 · Cited by 60
A genetically modified minipig model for Alzheimer’s disease with SORL1 haploinsufficiency
Andersen, O. M., Bøgh, N., Landau, A. M., Pløen, G. G., Jensen, A. M. G., Monti, G., Ulhøi, B. P., Nyengaard, J. R., Jacobsen, K. R., Jørgensen, M. M., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100740 · Cited by 48
Advances in treatment of frontotemporal dementia
Magrath Guimet, N., Zapata-Restrepo, L. M., & Miller, B. L. (2022) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.21060166 · Cited by 52
A fin-loop-like structure in GPX4 underlies neuroprotection from ferroptosis
Lorenz, S., Wahida, A., Bostock, M. J., Seibt, T., Mourão, A., Levkina, A., Trümbach, D., Soudy, M., Emler, D., Rothammer, N., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.014 · Cited by 61
Rare Neurodegenerative Diseases: Clinical and Genetic Update
Matilla‐Dueñas, A., Corral‐Juan, M., Rodríguez‐Palmero, A., Vilas, D., Ispierto, L., Morais, S., Sequeiros, J., Alonso, I. D. C. M. P., Volpini, V., Serrano, C., et al. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67144-4_25 · Cited by 52
Petit, D., Hitzenberger, M., Lismont, S., Zoltowska, K. M., Ryan, N. S., Mercken, M. H., Bischoff, F., Zacharias, M., & Chávez‐Gutiérrez, L. (2019) · The EMBO Journal · doi:10.15252/embj.2019101494 · Cited by 50
Copy Number Variants in Alzheimer’s Disease
Cuccaro, D., Marco, E. V. D., Cittadella, R., & Cavallaro, S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160469 · Cited by 51
The P2X7 receptor: a new therapeutic target in Alzheimer’s disease
Illés, P., Rubini, P., Huang, L., & Tang, Y. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1575811 · Cited by 50
Relationship between Wine Consumption, Diet and Microbiome Modulation in Alzheimer’s Disease
Moreno-Arribas, M. V., Bartolomé, B., Peñalvo, J. L., Pérez‐Matute, P., & Motilva, M. (2020) · Nutrients · doi:10.3390/nu12103082 · Cited by 50
Stanciu, G. D., Rusu, R. N., Bild, V., Filipiuc, L. E., Tamba, B.-I., & Ababei, D. C. (2021) · Biomedicines · doi:10.3390/biomedicines9050576 · Cited by 47
Early- and Late-Onset Alzheimer’s Disease: Two Sides of the Same Coin?
Valdez-Gaxiola, C. A., Rosales-Leycegui, F., Gaxiola-Rubio, A., Moreno-Ortíz, J. M., & Figuera, L. E. (2024) · Diseases · doi:10.3390/diseases12060110 · Cited by 55
Andrographolide Reduces Neuroinflammation and Oxidative Stress in Aged Octodon degus
Lindsay, C. B., Zolezzi, J. M., Rivera, D. S., Cisternas, P., Bozinovic, F., & Inestrosa, N. C. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01784-6 · Cited by 48
Hernández-Sapiéns, M. A., Reza-Zaldívar, E. E., Cevallos, R. R., Márquez-Aguirre, A. L., Gazarian, K. G., & Canales-Aguirre, A. A. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00151 · Cited by 46
Mutation screening in Chinese patients with familial Alzheimer's disease by whole-exome sequencing
Jiang, B., Zhou, J., Li, H., Chen, Y., Cheng, H.-R., Ye, L., Liu, D., Chen, D.-F., Tao, Q., & Wu, Z. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.11.024 · Cited by 47
Podvin, S., Jones, A. C., Liu, Q., Aulston, B. D., Ransom, L., Ames, J., Shen, G., Lietz, C. B., Jiang, Z., O’Donoghue, A. J., et al. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra120.002079 · Cited by 47
Homann, J., Osburg, T., Ohlei, O., Dobricic, V., Deecke, L., Bos, I., Vandenberghe, R., Gabel, S., Scheltens, P., Teunissen, C. E., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.840651 · Cited by 46
Self-citationImplications of the Approval of Lecanemab for Alzheimer Disease Patient Care
Knopman, D. S., & Hershey, L. A. (2023) · Neurology · doi:10.1212/wnl.0000000000207438 · Cited by 47
Marino, C., Perez‐Corredor, P., O'Hare, M., Heuer, A., Chmielewska, N., Gordon, H., Chandrahas, A. S., Gonzalez‐Buendia, L., Delgado‐Tirado, S., Doan, T. H., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13436 · Cited by 45
Alzheimer’s genes in microglia: a risk worth investigating
Sudwarts, A., & Thinakaran, G. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00679-4 · Cited by 52
Knockdown of Amyloid Precursor Protein: Biological Consequences and Clinical Opportunities
Gabriele, R. M. C., Abel, E., Fox, N. C., Wray, S., & Arber, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.835645 · Cited by 44
Systems healthcare: a holistic paradigm for tomorrow
Fiandaca, M. S., Mapstone, M. E., Connors, E. E., Jacobson, M., Monuki, E. S., Malik, S., Macciardi, F. M., & Federoff, H. J. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0521-2 · Cited by 49
Recent advancements toward therapeutic vaccines against Alzheimer’s disease
Herline, K., Drummond, E., & Wısnıewskı, T. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1500905 · Cited by 46
Polis, B., & Samson, A. O. (2024) · Journal of Alzheimer's Disease · doi:10.3233/jad-240058 · Cited by 43
State of Play in Alzheimer’s Disease Genetics
Zhu, J.-B., Tan, C., Tan, L., & Yu, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170062 · Cited by 44
Damotte, V., van der Lee, S. J., Chouraki, V. A., Grenier‐Boley, B., Simino, J. M., Adams, H. H. H., Tosto, G., White, C. C., Terzikhan, N., Cruchaga, C., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12333 · Cited by 40
Effectiveness of Physical Exercise on Alzheimer's disease. A Systematic Review
Cámara‐Calmaestra, R., Martínez‐Amat, A., Aibar‐Almazán, A., Hita‐Contreras, F., de Miguel‐Hernando, N., & Achalandabaso‐Ochoa, A. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.57 · Cited by 42
The impact of rare genetic variants on Alzheimer disease
Deyn, L. D., & Sleegers, K. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01062-1 · Cited by 44
Self-citationAlzheimer’s Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint
Alawode, D. O. T., Fox, N. C., Zetterberg, H., & Heslegrave, A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.837390 · Cited by 41
Genetic networks in Parkinson’s and Alzheimer’s disease
Kelly, J., Moyeed, R. A., Carroll, C., Luo, S., & Li, X. (2020) · Aging · doi:10.18632/aging.102943 · Cited by 41
Decoding metabolic signatures in Alzheimer’s disease: a mitochondrial perspective
Bano, D., Ehninger, D., & Bagetta, G. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01732-3 · Cited by 41
2023 China Alzheimer’s disease: facts and figures
Xiao, J., Li, J., Wang, J., Zhang, X., Wang, C., Peng, G., Hu, H., Liu, H., Liu, J., Shen, L., et al. (2023) · Human Brain · doi:10.37819/hb.3.1771 · Cited by 41
Firdaus, Z., & Li, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042320 · Cited by 46
Modulating Hinge Flexibility in the APP Transmembrane Domain Alters γ-Secretase Cleavage
Götz, A., Mylonas, N. T., Högel, P., Silber, M., Heinel, H., Menig, S., Vogel, A., Feyrer, H., Huster, D., Luy, B., et al. (2019) · Biophysical Journal · doi:10.1016/j.bpj.2019.04.030 · Cited by 42
Laval, K., & Enquist, L. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.658695 · Cited by 43
Challenge accepted: uncovering the role of rare genetic variants in Alzheimer’s disease
Khani, M., Gibbons, E., Bras, J., & Guerreiro, R. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00505-9 · Cited by 39
A task force for diagnosis and treatment of people with Alzheimer’s disease in Latin America
Lopera, F. J., Custodio, N., Rico-Restrepo, M., Allegri, R., Barrientos, J. D., Batres, E. G., Calandri, I. L., Moscoso, C., Caramelli, P., Quiroz, J. C. D., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1198869 · Cited by 42
Ali, J., Choe, K., Park, J. S., Park, H. Y., Kang, H., Park, T. J., & Kim, M.-O. (2024) · Antioxidants · doi:10.3390/antiox13070862 · Cited by 42
Next Generation Sequencing Analysis in Early Onset Dementia Patients
Bonvicini, C., Initiative, A. D. N., Scassellati, C., Benussi, L., Maria, E. D., Maj, C., Ciani, M., Fostinelli, S., Mega, A., Bocchetta, M., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180482 · Cited by 37
Emerging genetic complexity and rare genetic variants in neurodegenerative brain diseases
Perrone, F., Cacace, R., van der Zee, J., & Broeckhoven, C. V. (2021) · Genome Medicine · doi:10.1186/s13073-021-00878-y · Cited by 38
Self-citationThe Perspective of Dysregulated LncRNAs in Alzheimer's Disease: A Systematic Scoping Review
Asadi, M. R., Hassani, M., Kiani, S., Sabaie, H., Moslehian, M. S., Kazemi, M., Ghafouri‐Fard, S., Taheri, M. N., & Rezazadeh, M. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.709568 · Cited by 38
The ABC's of Alzheimer risk gene ABCA7
Duchateau, L., Wawrzyniak, N., & Sleegers, K. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13805 · Cited by 35
Self-citationEndres, K. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.310669 · Cited by 37
Marine Sources of DHA-Rich Phospholipids with Anti-Alzheimer Effect
Ferreira, I., Rauter, A. P., & Bandarra, N. M. (2022) · Marine Drugs · doi:10.3390/md20110662 · Cited by 42
The brain on time: links between development and neurodegeneration
Shabani, K., & Hassan, B. A. (2023) · Development · doi:10.1242/dev.200397 · Cited by 39
Dysregulated Metabolism of the Amyloid‐β Protein and Therapeutic Approaches in Alzheimer Disease
Kikuchi, K., Kidana, K., Tatebe, T., & Tomita, T. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26129 · Cited by 34
New Insights into the Molecular Bases of Familial Alzheimer’s Disease
D’Argenio, V., & Sarnataro, D. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10020026 · Cited by 35
Multifaceted Alzheimer’s Disease: Building a Roadmap for Advancement of Novel Therapies
Kaur, D., Behl, T., Sehgal, A., Singh, S., Sharma, N., & BUNGAU, S. G. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03415-w · Cited by 34
Hubbard, E. E., Heil, L. R., Merrihew, G. E., Chhatwal, J. P., Farlow, M. R., McLean, C., Ghetti, B. F., Newell, K. L., Frosch, M. P., Bateman, R. J., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00558 · Cited by 33
Hendrix, J. A., Airey, D. C., Britton, A. F., Burke, A. D., Capone, G. T., Chavez, R., Chen, J. M., Chicoine, B. A., Costa, A. C. S., Dage, J. L., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091907 · Cited by 33
Particulate matter and Alzheimer’s disease: an intimate connection
O’Piela, D. R., Durisek, G., Escobar, Y.-N. H., Mackos, A. R., & Wold, L. E. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.06.004 · Cited by 36
FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease
Yan, T., Liang, J., Gao, J., Wang, L., Fujioka, H., Initiative, T. A. D. N., Weiner, M. W., Schuff, N. W., Rosen, H. J., Miller, B. L., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13962-0 · Cited by 32
Kessissoglou, I. A., Langui, D., Hasan, A., Maral, M., Dutta, S. B., Hiesinger, P. R., & Hassan, B. A. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000703 · Cited by 35
Wang, X., Gao, F., Xu, W., Cao, Y., Wang, J., & Zhu, G. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1020614 · Cited by 32
Wang, Z., Zhang, Q., Lin, J.-R., Jabalameli, M. R., Mitra, J., Nguyen, N., & Zhang, Z. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-99352-3 · Cited by 29
Li, Z., Zhao, T., Shi, M., Wei, Y., Huang, X., Shen, J., Zhang, X., Xie, Z., Huang, P., Yuan, K., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1139558 · Cited by 33
Nemes, S., Logan, P. E., Manchella, M. K., Mundada, N. S., Joie, R. L., Polsinelli, A. J., Hammers, D. B., Koeppe, R. A., Foroud, T., Nudelman, K. N. H., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13403 · Cited by 32
Blue, E., Bis, J. C., Dorschner, M. O., Tsuang, D. W., Barral, S., Beecham, G. W., Below, J. E., Bush, W. S., Butkiewicz, M., Cruchaga, C., et al. (2018) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000485503 · Cited by 30
Perrone, F., Cacace, R., Mossevelde, S. V., den Bossche, T. V., Deyn, P. P. D., Cras, P. P., Engelborghs, S., van der Zee, J., & Broeckhoven, C. V. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.04.015 · Cited by 30
Self-citationAlzheimer’s disease: a tale of two diseases?
Nardini, E., Hogan, R., Flamier, A., & Bernier, G. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.308070 · Cited by 33
Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview
Štrac, D. Š., Konjevod, M., Šagud, M., Perković, M. N., Erjavec, G. N., Vuić, B., Šimić, G., Vukić, V., Mimica, N., & Pivac, N. (2021) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s284615 · Cited by 30
Liu, N., Zhang, T., Ma, L., Wei, W., Li, Z., Jiang, X., Sun, J., Pei, H., & Li, H. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab074 · Cited by 30
Role of TET1-mediated epigenetic modulation in Alzheimer's disease
Armstrong, M. J., Jin, Y., Vattathil, S., Huang, Y., Schroeder, J. P., Bennet, D. A., Qin, Z. S., Wingo, T. S., & Jin, P. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106257 · Cited by 32
Chou, C., Liao, Y., Lee, W., Wang, S., & Fuh, J. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0222-x · Cited by 29
Genetic meta-analysis identifies 9 novel loci and functional pathways for Alzheimer’s disease riskPreprint
Jansen, I. E., Savage, J. E., Watanabe, K., Bryois, J., Williams, D. M., Steinberg, S., Sealock, J., Karlsson, I., Hägg, S., Athanasiu, L., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/258533 · Cited by 33
Aberrant splicing of PSEN2 , but not PSEN1 , in individuals with sporadic Alzheimer’s disease
Course, M. M., Gudsnuk, K. M., Keene, C. D., Bird, T. D., Jayadev, S., & Valdmanis, P. N. (2022) · Brain · doi:10.1093/brain/awac294 · Cited by 33
Yuan, L., Zhang, J., Guo, J., Hölscher, C., Yang, J., Wu, M., Wang, Z.-J., Cai, H.-Y., Han, L., Shi, H., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201262 · Cited by 27
Bevilacqua, R., Barbarossa, F., Fantechi, L., Fornarelli, D., Paci, E., Bolognini, S., Giammarchi, C., Lattanzio, F., Paciaroni, L., Riccardi, G. R., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165432 · Cited by 33
Mezencev, R., & Chernoff, Y. O. (2020) · Cancers · doi:10.3390/cancers12040796 · Cited by 27
Lim, K., & Joo, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093398 · Cited by 28
Amyloid-β1–43 cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations
Perrone, F., Bjerke, M., Hens, E., Sieben, A., Timmers, M., Roeck, A. D., Vandenberghe, R. R., Sleegers, K., Martin, J., Deyn, P. P. D., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00676-5 · Cited by 28
Self-citationViaña, J. N. M., Bittlinger, M., & Gilbert, F. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161073 · Cited by 29
Çelik, H., Karahan, H., & Kelicen‐Uğur, P. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13208 · Cited by 28
Qureshi, Y. H., Baez, P., & Reitz, C. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00262-20 · Cited by 25
Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer’s Disease
Drummond, E., Goñi, F., Liu, S., Prelli, F., Scholtzova, H., & Wısnıewskı, T. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179909 · Cited by 26
Suñé-Pou, M., Limeres, M. J., Moreno‐Castro, C., Hernández-Munaín, C., Suñé-Negre, J. M., Cuestas, M. L., & Suñé, C. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00731 · Cited by 27
The Mechanistic Role of Bridging Integrator 1 (BIN1) in Alzheimer’s Disease
Gao, P.-R., Ye, L., Cheng, H.-R., & Li, H. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00926-y · Cited by 34
Chakraborty, S., Rakshit, J., Bandyopadhyay, J., & Basu, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.02.073 · Cited by 26
Rubin, L., Ingram, L. A., Resciniti, N. V., Ashford‐Carroll, B., Leith, K. H., Rose, A., Ureña, S., McCollum, Q., & Friedman, D. B. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.784958 · Cited by 27
Mutational analysis of PRNP in Alzheimer’s disease and frontotemporal dementia in China
Zhang, W., Jiao, B., Xiao, T., Pan, C., Liu, X., Zhou, L., Tang, B., & Shen, L. H. (2016) · Scientific Reports · doi:10.1038/srep38435 · Cited by 25
Umeda, T., Kimura, T., Yoshida, K., Takao, K., Fujita, Y., Matsuyama, S., Sakai, A., Yamashita, M., Yamashita, Y., Ohnishi, K., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0461-5 · Cited by 26
Neuroepigenetics and Alzheimer’s Disease: An Update
Zusso, M., Barbierato, M., Facci, L., Skaper, S. D., & Giusti, P. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180259 · Cited by 28
New molecular approaches to Alzheimer's disease
Resta, C. D., & Ferrari, M. (2019) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2019.04.010 · Cited by 26
Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer’s Disease?
Siokas, V., Aslanidou, P., Aloizou, A., Peristeri, E., Stamati, P., Liampas, I., Arseniou, S., Drakoulis, N., Aschner, M., Tsatsakis, A. M., et al. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01507-w · Cited by 49
Impaired autophagy in amyloid-beta pathology: A traditional review of recent Alzheimer's research
Yuan, M., Wang, Y., Huang, Z., Jing, F., Qiao, P., Zou, Q., Li, J., & Cai, Z. (2022) · Journal of Biomedical Research · doi:10.7555/jbr.36.20220145 · Cited by 26
Transcriptomic profiling of sporadic Alzheimer’s disease patients
Caldwell, A. B., Anantharaman, B. G., Ramachandran, S., Nguyen, P. A. H., Liu, Q., Trinh, I., Galasko, D. R., Desplats, P., Wagner, S. L., & Subramaniam, S. (2022) · Molecular Brain · doi:10.1186/s13041-022-00963-2 · Cited by 27
Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection
Воронин, М. В., Абрамова, Е. В., Verbovaya, E. R., Vakhitova, Y. V., & Середенин, С. Б. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010823 · Cited by 27
Circadian regulation in aging: Implications for spaceflight and life on earth
Malhan, D., Schoenrock, B., Yalçın, M., Blottner, D., & Relógio, A. (2023) · Aging Cell · doi:10.1111/acel.13935 · Cited by 25
Jensen, A. M. G., Raska, J., Fojtik, P., Monti, G., Lunding, M., Bartova, S., Pospisilova, V., van der Lee, S. J., Van Dongen, J., Bossaerts, L., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2408262121 · Cited by 22
Self-citationTau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease
Stancu, I., Ferraiolo, M., Terwel, D., & Dewachter, I. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_13 · Cited by 23
Selective neuronal vulnerability in Alzheimer’s disease
Wang, Z.-T., Zhang, C. M., Wang, Y., Dong, Q., Tan, L., & Yu, J. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101114 · Cited by 24
Exogenous Aβ1-42 monomers improve synaptic and cognitive function in Alzheimer's disease model mice
Duan, Y., Lv, J., Zhang, Z., Chen, Z., Wu, H., Chen, J., Chen, Z., Yang, J., Wang, D., Liu, Y., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109002 · Cited by 24
Bartoletti‐Stella, A., Baiardi, S., Maserati, M. S., Piras, S., Caffarra, P., Raggi, A., Pantieri, R., Baldassari, S., Caporali, L., Abu‐Rumeileh, S., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.02.006 · Cited by 23
Radiomic Features of the Hippocampus for Diagnosing Early-Onset and Late-Onset Alzheimer’s Disease
Du, Y., Zhang, S., Fang, Y., Qiu, Q., Zhao, L., Wei, W., Tang, Y., & Li, X. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.789099 · Cited by 23
Farkas, S., Szabó, A., Török, B., Sólyomvári, C., Fazekas, C. L., Bánrévi, K., Correia, P., Chaves, T., & Zelena, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.985424 · Cited by 25
Metadata
- Authors
- Cacace, R., Sleegers, K., & Van Broeckhoven, C.
- Affiliations
- University of Antwerp (BE)
- Neurodegenerative Brain Diseases group Department of Molecular Genetics VIB Antwerp Belgium
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2016-03-23
- Volume
- 12
- Issue
- 6
- Pages
- 733-748
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2306696647
- Cited by
- 617
- References
- 167
- Citations by year
- 2026: 34 · 2025: 71 · 2024: 60 · 2023: 90 · 2022: 85 · 2021: 88 · 2020: 61 · 2019: 49 · 2018: 35 · 2017: 32 · 2016: 11
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Alzheimer s & Dementia (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Fonds Wetenschappelijk Onderzoek
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- early-onset Alzheimer's disease, familial Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Apolipoproteins E, Humans, Models, Molecular, Molecular Biology, Mutation, Amyloid beta-Protein Precursor, Presenilin-1, Presenilin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
